Affinage

OPHN1

Oligophrenin-1 · UniProt O60890

Length
802 aa
Mass
91.6 kDa
Annotated
2026-06-10
27 papers in source corpus 8 papers cited in narrative 8 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 5/5 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

OPHN1 is a Rho GTPase-activating protein that couples suppression of Rho signaling to control of the actin cytoskeleton and to membrane dynamics at neuronal synapses (PMID:12932438, PMID:19481455). Its RhoGAP domain inhibits Rho pathways and is held in check by an intramolecular autoinhibitory mechanism mediated by its amino-terminal region, while a distinct carboxy-terminal domain binds F-actin and localizes the protein to the tips of growing neurites (PMID:12932438). At presynaptic terminals OPHN1 complexes with the membrane curvature-generating protein endophilin A1, and both this interaction and its Rho-GAP activity are required to set the kinetic efficiency of synaptic vesicle endocytosis (PMID:19481455). Postsynaptically, OPHN1 binds Homer1b/c to position the endocytic zone adjacent to the postsynaptic density, a configuration needed for AMPA receptor recycling, surface accumulation, and activity-dependent synaptic potentiation (PMID:24966368). A mechanistically separate function operates during plasticity: mGluR1 activation triggers rapid dendritic synthesis of OPHN1, and this newly made protein mediates mGluR-LTD and persistent loss of surface AMPARs through interactions with endophilin A2/3, distinct from its Homer1b/c-dependent role in basal synaptic strength (PMID:22017989). Beyond neurons, OPHN1 in hippocampal astrocytes controls synaptic transmission and short-term plasticity via an adenosine A1 receptor-dependent presynaptic pathway whose deficits are reversed by RhoA/ROCK inhibition [PMID:bio_10.1101_2025.01.09.632152].

Mechanistic history

Synthesis pass · year-by-year structured walk · 8 steps
  1. 2003 Medium

    Established OPHN1 as an actin-regulatory RhoGAP and defined its domain logic, answering what biochemical activity the protein carries and how that activity is controlled.

    Evidence Overexpression, co-localization, and domain deletion analysis in fibroblasts with in vivo actin cytoskeleton assays

    PMID:12932438

    Open questions at the time
    • Activity demonstrated largely by overexpression in non-neuronal cells, not endogenous neuronal context
    • Identity of the Rho-family substrate(s) preferentially regulated not resolved
    • Physiological trigger that relieves N-terminal autoinhibition unknown
  2. 2009 High

    Showed OPHN1 acts presynaptically through a defined partner, answering how its GAP activity is deployed at synapses by linking it to endophilin A1 and synaptic vesicle endocytosis.

    Evidence Reciprocal Co-IP, shRNA knockdown in hippocampal neurons, FM-dye live imaging of SV cycling, and domain-specific epistasis

    PMID:19481455

    Open questions at the time
    • How Rho-GAP activity and endophilin binding are coordinated mechanistically not resolved
    • Whether OPHN1 acts during a specific endocytic step versus globally unclear
  3. 2011 High

    Separated two OPHN1 functions, answering whether basal and plasticity roles are the same mechanism by showing mGluR1-triggered dendritic synthesis drives mGluR-LTD via endophilin A2/3 while basal strength requires GAP activity plus Homer1b/c.

    Evidence Acute translational blockade, Co-IP with endophilin A2/3 and Homer1b/c, hippocampal slice electrophysiology, surface AMPAR quantification, and shRNA

    PMID:22017989

    Open questions at the time
    • Signaling that couples mGluR1 activation to OPHN1 mRNA translation not defined
    • How locally synthesized OPHN1 selects endophilin A2/3 over A1 unknown
  4. 2014 High

    Explained how OPHN1 organizes the postsynaptic membrane, answering why Homer1b/c binding matters by showing it positions the endocytic zone next to the PSD for AMPAR recycling and potentiation.

    Evidence Reciprocal Co-IP, shRNA knockdown, live imaging of endocytic zone positioning, AMPAR surface assays, and hippocampal slice electrophysiology

    PMID:24966368

    Open questions at the time
    • Structural basis of the OPHN1-Homer1b/c interaction not determined
    • Whether GAP activity contributes to EZ positioning separate from the scaffolding role unclear
  5. 2014 Medium

    Documented developmental regulation of the transcript, answering whether OPHN1 is post-transcriptionally tuned by showing ADAR2-mediated A-to-I editing and alternative splicing peaking during human fetal brain development.

    Evidence Sequencing of OPHN1 cDNA from fetal and adult human brain with RT-PCR and editing quantification

    PMID:24637888

    Open questions at the time
    • Functional consequence of edited/spliced isoforms on protein activity not tested
    • Whether editing alters domain function or localization unknown
  6. 2013 Low

    Probed the BAR domain's specific contribution, addressing whether N-terminal regions have hippocampus-specific roles via an in-frame BAR-domain deletion associated with hippocampal alterations distinct from null mutations.

    Evidence cDNA and splicing analysis of a single family with MRI correlation

    PMID:24105372

    Open questions at the time
    • Single family with no direct functional assay of BAR domain activity
    • Mechanism linking BAR deletion to hippocampal phenotype not established
  7. 2026 Low

    Implicated the PH domain in phosphoinositide-directed localization, addressing how OPHN1 is targeted within cells via a K306N variant that enhances PI4P/PI5P binding and is linked to cyclic strabismus without intellectual disability.

    Evidence Single-patient variant identification, in vitro phosphoinositide binding assay, and clinical phenotyping

    PMID:42031848

    Open questions at the time
    • Single patient with in vitro binding only, no functional rescue or localization experiment
    • Causal link between altered lipid binding and the strabismus phenotype unproven
  8. 2025 Medium

    Extended OPHN1 function beyond neurons, addressing the cell-autonomy of its synaptic roles by showing astrocyte-specific deficiency impairs transmission and memory via an adenosine A1 receptor pathway rescuable by RhoA/ROCK inhibition.

    Evidence Postnatal astrocyte-restricted conditional Ophn1 knockdown with electrophysiology, behavior, morphology, and pharmacological rescue (preprint)

    PMID:bio_10.1101_2025.01.09.632152

    Open questions at the time
    • Preprint, single lab, not peer-reviewed
    • How astroglial RhoA/ROCK signaling engages presynaptic A1 receptors mechanistically unclear
    • Relative contribution of astroglial versus neuronal OPHN1 to circuit phenotypes not partitioned

Open questions

Synthesis pass · forward-looking unresolved questions
  • How OPHN1's autoinhibition, phosphoinositide binding, and partner selection are integrated to direct context-specific functions across pre-, post-synaptic, and astroglial compartments remains unresolved.
  • No structural model integrating BAR, PH, GAP, and proline-rich domains in a functional state
  • Upstream signals relieving autoinhibition in each compartment not identified
  • Preferred Rho-family substrate(s) in vivo not defined

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0008092 cytoskeletal protein binding 1 GO:0008289 lipid binding 1 GO:0060090 molecular adaptor activity 1 GO:0098772 molecular function regulator activity 1
Localization
GO:0005886 plasma membrane 2 GO:0005856 cytoskeleton 1
Pathway
R-HSA-112316 Neuronal System 2 R-HSA-162582 Signal Transduction 2 R-HSA-5653656 Vesicle-mediated transport 2

Evidence

Reading pass · 8 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2003 OPHN1 is a novel F-actin-binding protein; its RhoGAP domain inhibits Rho pathways and regulates the actin cytoskeleton in vivo, while its amino-terminal domain negatively controls RhoGAP activity through an intramolecular inhibitory mechanism. OPHN1 colocalizes with actin at the tip of growing neurites, and the F-actin interaction is mediated by a novel carboxyl-terminal domain. Overexpression in fibroblasts; co-localization studies; domain deletion/overexpression analysis; in vivo actin cytoskeleton assays Molecular and cellular neurosciences Medium 12932438
2009 OPHN1 forms a complex with endophilin A1 (a membrane curvature-generating protein) at presynaptic sites, and both this interaction and OPHN1's Rho-GAP activity are required for OPHN1's role in controlling the kinetic efficiency of synaptic vesicle endocytosis at hippocampal synapses. OPHN1 knockdown impairs the SV cycling/endocytosis rate. Co-immunoprecipitation; shRNA knockdown in hippocampal neurons; live fluorescence imaging of SV cycling (FM dye assays); epistasis with endophilin A1 Current biology : CB High 19481455
2011 mGluR1 activation induces rapid dendritic synthesis of OPHN1 (independent of FMRP), and this newly synthesized OPHN1 mediates mGluR-LTD and persistent decreases in surface AMPARs via interactions with endophilin A2/3. Separately, OPHN1's role in basal synaptic strength requires its Rho-GAP activity and interaction with Homer1b/c, distinguishing two mechanistically distinct functions. Acute OPHN1 synthesis blockade; Co-immunoprecipitation with endophilin A2/3 and Homer1b/c; hippocampal slice electrophysiology; surface AMPAR quantification; shRNA knockdown Neuron High 22017989
2014 OPHN1 physically interacts with Homer1b/c, and this interaction is crucial for positioning the endocytic zone (EZ) adjacent to the postsynaptic density (PSD) in dendritic spines. Disruption of the OPHN1-Homer1b/c interaction displaces EZs from the PSD, impairs AMPAR recycling and accumulation at synapses, and reduces activity-dependent synaptic potentiation in rat hippocampus. Co-immunoprecipitation; shRNA knockdown; live-cell fluorescence imaging of EZ positioning; AMPAR surface quantification; electrophysiology in hippocampal slices The Journal of neuroscience : the official journal of the Society for Neuroscience High 24966368
2013 An in-frame deletion removing 37 amino acids from the conserved N-terminal BAR domain of OPHN1 produces a stable mutant transcript and is associated with hippocampal alterations not seen in canonical loss-of-function mutations, suggesting the BAR domain has a distinct functional role in the hippocampus. cDNA expression analysis; mRNA splicing analysis; MRI neuroimaging correlation with BAR domain deletion European journal of human genetics : EJHG Low 24105372
2014 OPHN1 transcript undergoes ADAR2-mediated A-to-I RNA editing and alternative splicing in human brain during development, with editing detectable from gestational week 18 and peaking at weeks 20–33 coinciding with increased OPHN1 expression and the appearance of a novel splicing isoform. Sequencing of OPHN1 cDNA from human fetal and adult brain; RT-PCR; A-to-I editing quantification PloS one Medium 24637888
2026 A K306N variant in the PH domain of OPHN1 (outside the BAR and GAP domains) enhances OPHN1 binding to phosphatidylinositol phosphates PI4P and PI5P, and is associated with cyclic strabismus without intellectual disability, suggesting that PH domain-mediated phosphoinositide binding influences subcellular localization of OPHN1. Identification of hemizygous variant; in vitro phosphoinositide binding assay; clinical phenotyping Scientific reports Low 42031848
2025 Postnatal Ophn1 deficiency specifically in hippocampal astrocytes impairs synaptic transmission, short-term plasticity, and spatial working memory in adults. The mechanism involves an adenosine A1 receptor-dependent presynaptic pathway associated with increased astroglial synapse coverage (morphological rearrangement). These deficits are rescued by pharmacological inhibition of the RhoA/ROCK pathway. Cell-type-specific conditional Ophn1 knockdown (postnatal, astrocyte-restricted); electrophysiology; behavioral testing (spatial working memory); morphological analysis of astroglial coverage; pharmacological RhoA/ROCK inhibition rescue bioRxivpreprint Medium bio_10.1101_2025.01.09.632152

Source papers

Stage 0 corpus · 27 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2003 Oligophrenin 1 (OPHN1) gene mutation causes syndromic X-linked mental retardation with epilepsy, rostral ventricular enlargement and cerebellar hypoplasia. Brain : a journal of neurology 96 12805098
2003 The RhoGAP activity of OPHN1, a new F-actin-binding protein, is negatively controlled by its amino-terminal domain. Molecular and cellular neurosciences 83 12932438
2009 The Rho-linked mental retardation protein OPHN1 controls synaptic vesicle endocytosis via endophilin A1. Current biology : CB 63 19481455
2011 Rapid synthesis of the X-linked mental retardation protein OPHN1 mediates mGluR-dependent LTD through interaction with the endocytic machinery. Neuron 58 22017989
2007 Contiguous gene deletions involving EFNB1, OPHN1, PJA1 and EDA in patients with craniofrontonasal syndrome. Clinical genetics 36 17941886
2011 Novel intragenic deletion in OPHN1 in a family causing XLMR with cerebellar hypoplasia and distinctive facial appearance. Clinical genetics 26 20528889
1990 Expression of constitutive and inducible HSP70 and HSP47 is enhanced in cells persistently spread on OPN1 or collagen. Biochemical and biophysical research communications 26 2222462
2005 Delineation of the clinical phenotype associated with OPHN1 mutations based on the clinical and neuropsychological evaluation of three families. American journal of medical genetics. Part A 25 16158428
2013 A novel in-frame deletion affecting the BAR domain of OPHN1 in a family with intellectual disability and hippocampal alterations. European journal of human genetics : EJHG 23 24105372
2014 The X-linked mental retardation protein OPHN1 interacts with Homer1b/c to control spine endocytic zone positioning and expression of synaptic potentiation. The Journal of neuroscience : the official journal of the Society for Neuroscience 19 24966368
2021 Targeting the Lnc-OPHN1-5/androgen receptor/hnRNPA1 complex increases Enzalutamide sensitivity to better suppress prostate cancer progression. Cell death & disease 16 34545067
2008 Deletion of the OPHN1 gene detected by aCGH. Journal of intellectual disability research : JIDR 14 18261018
2018 Expanding the phenotypic spectrum associated with OPHN1 mutations: Report of 17 individuals with intellectual disability but no cerebellar hypoplasia. European journal of medical genetics 12 29510240
2018 Expanding the phenotypic spectrum associated with OPHN1 variants. European journal of medical genetics 11 29960046
2007 Report of a female patient with mental retardation and tall stature due to a chromosomal rearrangement disrupting the OPHN1 gene on Xq12. European journal of medical genetics 11 17845870
2014 Oligophrenin-1 (OPHN1), a gene involved in X-linked intellectual disability, undergoes RNA editing and alternative splicing during human brain development. PloS one 10 24637888
2013 Neuropathological features in a female fetus with OPHN1 deletion and cerebellar hypoplasia. European journal of medical genetics 10 23416624
2022 Circ-OPHN1 suppresses the proliferation, migration, and invasion of trophoblast cells through mediating miR-558/THBS2 axis. Drug development research 9 35277867
2021 Androgen deprivation‑induced OPHN1 amplification promotes castration‑resistant prostate cancer. Oncology reports 8 34738630
2020 Exon 21 deletion in the OPHN1 gene in a family with syndromic X-linked intellectual disability: Case report. Medicine 5 32872024
2021 Novel unconventional variants expand the allelic spectrum of OPHN1 gene. American journal of medical genetics. Part A 3 33638601
2011 Oligophrenin-1 (Ophn1) is expressed in mouse retinal vessels. Gene expression patterns : GEP 2 22119667
2025 The interaction of UBR4, LRP1, and OPHN1 in refractory epilepsy: Drosophila model to investigate the oligogenic effect on epilepsy. Neurobiology of disease 1 40374006
2024 Exome Sequencing of Consanguineous Pashtun Families With Familial Epilepsy Reveals Causative and Candidate Variants in TSEN54, MOCS2, and OPHN1. Clinical genetics 1 39400946
2026 A novel OPHN1 variant associated with cyclic strabismus but in the absence of OPHN1 syndrome. Scientific reports 0 42031848
2024 Effect of the OPHN1 novel variant c.1025+1 G>A on RNA splicing: insights from a minigene assay. BMC medical genomics 0 38956616
2008 [Anassociation study between OPHN1 gene rs492933 polymorphism and mental retardation in children of the Qinba Mountain region.]. Yi chuan = Hereditas 0 18930891

Missed literature

Know a paper Affinage missed for OPHN1? Flag it for the maintainers and the community.

No submissions yet.